Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Agenus Inc. logo

Agenus Inc.

Sector: Healthcare   

Industry: Biotechnology

1.88
 
USD
  
0.03
  
(1.62%)
Optionable: Yes  Market Cap: 645 M  90-day average vol: 5,203,234

Previous close: 1.85  Open: 1.92  Bid: 1.87  Ask: 1.9
52 week range    
1.25   
   3.37
Peers   
IDRA / 
NWBO / 
MRK / 
PARD / 
GSK / 
IMUC / 
BMY / 
CLDX / 
Last updated: Thursday 8th June 2023
45
MarketXLS Rank
40
Value
69
Technical
26
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

AGEN Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends3 M203832.0202960.0204246.0205541.0207000.0208000.0209000.0211000.0212000.0
Amortization-462000.0-525000.0-2 M-2 M-2 M-2 M-2 M-2 M-2 M
Amortization of intangibles-462000.0-525000.0-2 M-2 M-2 M-2 M-2 M-2 M-2 M
Basic EPS total-1.180.0-0.22-0.78
Basic weighted shares outstanding60 M78 M87 M98 M110772.0134982.0172504.0228919.0281743.0
Cost of sales-536118.0-2 M-3 M-11 M
Depreciation-600000.0-1 M-1 M-3 M-4 M-4 M-5 M-5 M-5 M-5 M
DepreciationAndAmortization-600000.0-1 M-1 M-3 M-4 M-4 M-5 M-5 M-5 M-5 M
Diluted EPS total-1.12-0.71-1.13-1.46-1.23-1.44-0.8-1.05-0.11-0.78
Diluted weighted shares outstanding281743.0
GainOnSaleOfPPE0.0
GeneralAndAdministrativeExpense14 M21 M28 M33 M34 M37 M46 M59 M76 M81 M
Gross operating profit3 M7 M25 M23 M43 M37 M150 M86 M292 M87 M
ImpairmentOfCapitalAssets0.00.00.00.00.00.0
Income before tax-30 M-42 M-93 M-127 M-121 M-162 M-112 M-180 M-29 M-229 M
Income restructuring and M&A39 M43 M
Income taxes-143000.0-5 M-7 M-105 M-10 M-9 M
Interest income-3 M834708.0-13 M-20 M-17 M-27 M-41 M-63 M-61 M-49 M
InterestExpenseNonOperating2 M-4 M-19 M-31 M
MinorityInterests6 M0.02 M4 M2 M5 M11 M
MiscOtherSpecialCharges-3 M-7 M-7 M-2 M3 M-9 M-6 M-1 M-5 M815000.0
Net income from total operations-30 M-42 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M
NetIncomeCommonStockholders-33 M-43 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M
NetIncomeContinuousOperations-30 M-42 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M
NetIncomeFromOtherGainsLosses-3 M-2 M
NetNonOperatingInterestIncomeExpense-5 M834708.0-13 M-20 M-17 M-27 M-41 M-63 M-61 M-49 M
Operating income-25 M-37 M-74 M-106 M-107 M-125 M-64 M-116 M37 M-180 M
Operating income before depreciation (EBITDA)-24 M-42 M-79 M-103 M-98 M-128 M-63 M-110 M39 M-172 M
OperatingExpense27 M44 M99 M128 M150 M162 M214 M202 M255 M268 M
OperatingRevenue3 M7 M25 M23 M43 M37 M150 M88 M296 M98 M
Other income net-4 M7 M7 M2 M-3 M9 M6 M1 M5 M-815000.0
Other special charges-481000.0-365000.0-780000.0-733000.0-562000.00.0
OtherGandA14 M21 M28 M33 M34 M37 M46 M59 M76 M81 M
OtherImpairmentOfCapitalAssets-6 M
OtherOperatingExpenses0.00.0-203000.0-3 M-5 M-9 M-9 M
OtherunderPreferredStockDividend3 M203832.0202960.0204246.0205541.0207000.0208000.0209000.0211000.0212000.0
PreferredStockDividends3 M203832.0202960.0204246.0205541.0207000.0208000.0209000.0211000.0212000.0
RentAndLandingFees14 M21 M28 M33 M34 M37 M46 M59 M76 M81 M
Research & development expense13 M22 M70 M95 M116 M125 M168 M143 M179 M187 M
ResearchExpense13 M22 M70 M95 M116 M125 M168 M143 M179 M187 M
RestructringAndMnAIncome39 M43 M
SalariesAndWages0.0-5 M-7 M-13 M-12 M-8 M-10 M-10 M-19 M-18 M
Selling Gen & administrative expense14 M21 M28 M33 M34 M37 M46 M59 M76 M81 M
Special income/charges-39 M-43 M780000.0733000.0562000.0
Total Income available for interest expense (EBIT)-25 M-43 M-81 M-107 M-104 M-135 M-70 M-117 M32 M-179 M
Total common shares outstanding349 M349 M349 M349 M349 M349 M349 M349 M349 M349 M
Total net income-30 M-42 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M
Total ordinary shares349 M349 M349 M349 M349 M349 M349 M349 M349 M349 M
Total revenues3 M7 M25 M23 M43 M37 M150 M88 M296 M98 M
TotalExpenses27 M44 M99 M128 M150 M162 M214 M199 M251 M257 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today